CVI Holdings’s Artelo Biosciences, Inc. Warrant ARTLW Stock Holding History

CVI Holdings’s Portfolio ARTLW Stock Details ARTLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-65,000	Closed	-$5K	–	196
2020 Q3	$5K	Hold	65,000	–	–	﹤0.01%	79
2020 Q2	$7K	Hold	65,000	–	–	﹤0.01%	67
2020 Q1	$4K	Hold	65,000	–	–	0.01%	31
2019 Q4	$19K	Hold	65,000	–	–	0.03%	29
2019 Q3	$38K	Hold	65,000	–	–	0.09%	28
2019 Q2	$55K	Buy	+65,000	New	+$56.7K	0.06%	44

Other funds holding ARTLW

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

CVI Holdings's ARTLW Position: Q4 2020 in Review

CVI Holdings sold out of Artelo Biosciences, Inc. Warrant (ARTLW) in Q4 2020, closing a stake of 65,000 shares — an estimated $5K sold.

CVI Holdings first reported a position in ARTLW in Q2 2019 and held it in 6 quarters. The position peaked at $55K in Q2 2019. 5 funds tracked by Wall St. Rank hold ARTLW as of Q4 2020.

CVI Holdings reported no remaining Artelo Biosciences, Inc. Warrant position as of Q4 2020 after selling out during the quarter.
CVI Holdings sold 65,000 Artelo Biosciences, Inc. Warrant shares in Q4 2020, an estimated $5K.
CVI Holdings first reported a position in Artelo Biosciences, Inc. Warrant in Q2 2019 and held it in 6 quarters.
CVI Holdings's Artelo Biosciences, Inc. Warrant position peaked at $55K in Q2 2019.
5 funds tracked by Wall St. Rank held Artelo Biosciences, Inc. Warrant as of Q4 2020.

Based on CVI Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.